22157.jpg
Global Power Tools Market Analysis Report 2024: A $56.19 Billion Industry in 2028, Driven by Rising Demand from Wind Energy Industry and Accelerating Adoption of Cordless Power Tools
April 16, 2024 07:07 ET | Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Global Power Tools Market (by Mode of Operation, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report...
Clearside Logo 2024.jpg
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
April 16, 2024 07:05 ET | Clearside Biomedical, Inc.
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
Flexible morals: A k
Flexible morals: A key reason American voters support divisive misinformation
April 16, 2024 07:05 ET | MIT Sloan School of Management
Houston, Texas and Cambridge, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Over the last decade or so, concern has grown over the tendency for Americans to support their favorite politicians even when...
22157.jpg
North America and US Packaging Market Analysis Report 2024: A $243.68 Billion Industry in 2028 with Branding Opportunities for Flexible Paper Packaging and Emergence of Sustainability in Packaging
April 16, 2024 07:04 ET | Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "North America Packaging Market with Focus on the US: Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ...
Charles Mah, Former Workday VP of TA, Joins GoodTime to Transform Hiring Experiences with Human-Centric AI
April 16, 2024 07:02 ET | GoodTime
Charles Mah joins GoodTime as the company’s Chief Customer and Operations Officer to help customers leverage human-centric AI for hiring efficiency.
Intra-Cellular_Logo_RGB_ALT.jpg
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
April 16, 2024 07:00 ET | Intra-Cellular Therapies Inc.
Lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key secondary endpoints Lumateperone 42 mg met the primary endpoint of change...
Logo.png
Gray Television Stations Win Large Market and Small Market Service to America Awards
April 16, 2024 07:00 ET | Gray Television, Inc.
ATLANTA, April 16, 2024 (GLOBE NEWSWIRE) -- The National Association of Broadcasters Leadership Foundation (“NABLF”) selected two television stations owned by Gray Television, Inc. (NYSE: GTN) for...
Foghorn®-logo-color.jpg
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer
April 16, 2024 07:00 ET | Foghorn Therapeutics, Inc.
CAMBRIDGE, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases...
eyepoint logo.png
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 16, 2024 07:00 ET | EyePoint Pharmaceuticals, Inc.
WATERTOWN, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of...
CECO-Environmental_SMALL.jpg
CECO Environmental to Release First Quarter Earnings and Host Conference Call on April 30
April 16, 2024 07:00 ET | CECO Environmental Corp.
Announcing Q1'24 release date and teleconference.